Filing Details

Accession Number:
0001593968-20-001546
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-06-30 16:25:47
Reporting Period:
2020-06-29
Accepted Time:
2020-06-30 16:25:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1771917 Karuna Therapeutics Inc. KRTX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1237564 M Steven Paul C/O Karuna Therapeutics, Inc.
33 Arch St Ste 3110
Boston MA 02110-1424
President &Amp; Ceo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-06-29 292,207 $0.11 398,692 No 4 M Indirect See footnote (1)
Common Stock Disposition 2020-06-29 292,207 $103.50 106,485 No 4 S Indirect See footnote (1)
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Indirect See footnote (1)
No 4 S Indirect See footnote (1)
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option (right to buy) Disposition 2020-06-29 292,207 $0.00 292,207 $0.11
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2011-03-04 2021-03-04 No 4 M Indirect
Footnotes
  1. The exercise and sale reported on this Form 4 were effected by the The Jann E. Paul Grantor Retained Annuity Trust I.